Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06459635

Migraine Attack Pain Phase Prediction Study

The study of the ability to predict pain in a migraine attack, through premonitory symptoms and through an ambulatory monitoring device through real-time recording of hemodynamic variables, is one of the strategic lines of research of the unit. of Headaches at the Hospital de La Princesa since 2013 together with the Complutense and Polytechnic University of Madrid. Their results have been reflected in various publications (Pagán J, et al. Sensors 2015; Gago-Veiga AB, et al. J Pain Res 2018) and have promoted the creation of several invention patents.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Universitario de La Princesa

Madrid, 28006, Spain

Location status: Recruiting

Location contact

Ana Beatriz Gago Veiga

CONTACT

[email protected]

+34 915202416

Ana Beatriz Gago Veiga

PRINCIPAL_INVESTIGATOR

Iris Fernández Lázaro

CONTACT

[email protected]

About this study

Patients with episodic migraine will be recruited from the monographic headache clinics of the 7 centers participating in the study. These patients, for a maximum period of 2 months, must monitor their hemodynamic variables with a wearable device and record all the clinical characteristics of their migraine attacks. Subsequently, with these records, an individualized algorithm will be created for each patient that aims to predict the onset of the migraine attack.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 15 years and 69 years.
  • Diagnosed with migraine by a headache neurologist and according to the criteria proposed by ICHD-3.
  • History of migraine of at least 1 year of evolution.
  • Normal neurological examination.
  • Have given your informed consent.
  • Be able to describe your clinical situation and the characteristics of your headache.
  • Have an average of 10 to 14 migraine days per month in the three months prior to inclusion (high-frequency episodic migraine).
  • User-level management capacity of "smartphone" type electronic devices.
  • Be able to complete two months of study follow-up.

Exclusion criteria

  • Presence of another type of headache, with the exception of headache due to excessive use of analgesic medication.
  • Cognitive deficiency or any other pathology that may prevent or make it difficult for the patient to perform the study correctly.
  • Neurological focus in the examination.
  • Pregnancy or breastfeeding period.
  • Patients with known heart disease or bronchopathy, Sjögren's syndrome, diabetes mellitus, or hypo/hyperthyroidism.
  • Carriers of pacemakers, neurostimulators or any other electronic device that is considered to make the interpretation of biometric records difficult.
  • Anatomical problem that makes the use of the device impossible.
  • Patients in whom it is expected that a change in migraine preventive treatment or other usual treatment will be possible during the study period.

Treatment and study plan

Primary outcomes

  1. Development of a prediction strategy for the onset of migraine

    Time frame: From the beginning of treatment, which is the initial visit, to 2 months of follow-up

    Develop a prediction strategy for the onset of migraine attacks in patients with episodic migraine, based on hemodynamic and clinical variables of migraine attacks.

Secondary outcomes

  1. Posibility of predict the onset of pain in a migraine attack

    Time frame: From the beginning of treatment, which is the initial visit, to 2 months of follow-up

    To analyze whether it is possible to predict the onset of pain in a migraine attack, through ambulatory and non-invasive monitoring of physiological variables.

  2. Individualized prediction algorithm

    Time frame: From the beginning of treatment, which is the initial visit, to 2 months of follow-up

    Implement an individualized prediction algorithm that allows real-time prediction of the symptomatic phase of the migraine attack.

  3. Effectiveness of the prediction model

    Time frame: From the beginning of treatment, which is the initial visit, to 2 months of follow-up

    Measure the effectiveness of the prediction model both at the individual level and in a large group of patients.

Study contacts

Contact information is provided by the study sponsor or research team.

Ana Beatriz Gago Veiga

CONTACT

[email protected]

+34 915202416

Iris Fernández Lázaro

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Other

Collaborators

  • Hospital Clínico Universitario Lozano Blesa
  • Hospital Clínico Universitario de Valladolid
  • Hospital Donostia
  • Hospital Universitario La Fe
  • Hospital Universitario Marqués de Valdecilla
  • Hospital Vall d'Hebron

Registry information

Official study title

Prediction Study of the Pain Phase of Migraine Attacks in Patients With Episodic Migraine

Acronym: PREDI-CRISIS

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Jun 14, 2024
Registry last updated
Jul 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.